Skip to main content
logo
ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
282.35
-0.93 (-0.33%)
At close: Oct 8, 2025, 4:00 PM EDT
283.69
+1.34 (0.47%)
After-hours: Oct 8, 2025, 7:34 PM EDT

ResMed Revenue

In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth. ResMed had revenue of $1.35B in the quarter ending June 30, 2025, with 10.20% growth.

Revenue (ttm)
$5.15B
Revenue Growth
+9.84%
P/S Ratio
8.05
Revenue / Employee
$515,664
Employees
9,980
Market Cap
41.20B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20255.15B461.03M9.84%
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

RMD News

More News